Skip to content

Form 4 filed by Kumar Neil

Kumar Neil filed this Form 4 on BBIO (BridgeBio Pharma, Inc.) with 9 transaction rows and 3 holding rows, accepted by EDGAR 2026-11-19 00:36:08 UTC.

Accession
0001743881-26-000039
Filed
2026-11-18
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: BBIO · BridgeBio Pharma, Inc. (CIK 1743881)

  • Kumar Neil director, officer (Chief Executive Officer)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-16M exercised+33,544276,871D
Common Stock 2026-11-16M exercised+19,599296,470D
Common Stock 2026-11-16M exercised+11,554308,024D
Common Stock 2026-11-16M exercised+6,519314,543D
Common Stock 2026-11-16F withheld for tax-36,236$77.36278,307D
Common Stock holding 495,686I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Common Stock holding 750,000I By NK 2026 GRAT
Common Stock holding 3,568,447I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Restricted Stock Units derivative2026-11-16M exercised-33,544$033,544D
Restricted Stock Units derivative2026-11-16M exercised-19,599$097,997D
Restricted Stock Units derivative2026-11-16M exercised-11,554$0103,984D
Restricted Stock Units derivative2026-11-16M exercised-6,519$084,755D